Alan S Cross Selected Research

Alan S Cross Research Topics

Disease

22	Infections 01/2022 - 12/2002
17	Sepsis (Septicemia) 01/2021 - 09/2002
5	Inflammation (Inflammations) 10/2014 - 12/2003
4	Anthrax 01/2012 - 11/2007
3	Endotoxemia 10/2016 - 12/2002
2	Communicable Diseases (Infectious Diseases) 07/2021 - 03/2008
2	Leukostasis 11/2019 - 02/2003
2	Peritonitis 01/2018 - 03/2015
2	Gram-Negative Bacterial Infections 03/2015 - 05/2008
2	Neoplasms (Cancer) 06/2012 - 03/2003
2	Edema (Dropsy) 01/2012 - 07/2011
1	Seroma 01/2022
1	Burns 01/2021
1	Wounds and Injuries (Trauma) 01/2018
1	Neonatal Sepsis 10/2016
1	Pneumococcal Infections 05/2015
1	Human Influenza (Influenza) 05/2015
1	Coinfection 03/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2014
1	Malnutrition (Nutritional Deficiencies) 10/2014
1	Typhoid Fever (Typhoid) 05/2014
1	Salmonella Infections (Salmonellosis) 05/2014
1	Meningitis 05/2014
1	Bacteremia 01/2014
1	Pulmonary Edema 11/2013
1	Acute Lung Injury 11/2013
1	Bacterial Infections (Bacterial Infection) 06/2013
1	Shock 06/2013
1	Septic Shock (Toxic Shock Syndrome) 06/2013
1	Soft Tissue Infections 06/2013
1	Neoplasm Metastasis (Metastasis) 06/2012
1	Pneumonia (Pneumonitis) 10/2008
1	Bacterial Pneumonia 10/2008
1	Cross Infection (Nosocomial Infection) 03/2008
1	Tularemia 07/2007

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 01/2022 - 09/2002
13	LipopolysaccharidesIBA 11/2015 - 09/2002
9	AntibodiesIBA 01/2019 - 11/2003
8	Membrane Proteins (Integral Membrane Proteins)IBA 11/2015 - 09/2002
7	CytokinesIBA 01/2022 - 10/2006
7	EndotoxinsIBA 01/2021 - 02/2004
6	AntigensIBA 07/2021 - 11/2007
5	Neuraminidase (Sialidase)IBA 11/2019 - 02/2003
3	Polysaccharides (Glycans)IBA 01/2019 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 06/2013 - 02/2003
2	ChemokinesIBA 01/2022 - 02/2003
2	FlagellinIBA 11/2021 - 11/2019
2	Immune Sera (Antisera)IBA 01/2018 - 01/2010
2	Interleukin-18 (Interleukin 18)IBA 10/2016 - 12/2002
2	Carrier Proteins (Binding Protein)IBA 05/2015 - 09/2014
2	Peptides (Polypeptides)IBA 03/2015 - 06/2013
2	AB103IBA 03/2015 - 06/2013
2	ArginaseIBA 04/2012 - 01/2012
2	edema factorIBA 01/2012 - 07/2011
2	GlycolipidsIBA 10/2010 - 12/2005
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2010 - 03/2009
2	Caspase 1 (ICE Protease)IBA 06/2008 - 12/2002
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2019
1	Conjugate VaccinesIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	GlycoconjugatesIBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2016
1	ProMune (CpG 7909)IBA 11/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2015
1	Galectins (Galectin)IBA 05/2015
1	Galectin 3 (LGALS3)IBA 05/2015
1	Galectin 1 (LGALS1)IBA 05/2015
1	LectinsIBA 05/2015
1	CarbohydratesIBA 05/2015
1	polysialic acidIBA 09/2014
1	LigandsIBA 11/2013
1	SuperantigensIBA 06/2013
1	ExotoxinsIBA 06/2013
1	Death-Associated Protein KinasesIBA 06/2012
1	EnzymesIBA 06/2012
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2012
1	Immunoglobulin G (IgG)IBA 07/2011
1	Anthrax Vaccines (Vaccines, Anthrax)IBA 07/2011
1	Biological Warfare AgentsIBA 12/2010
1	CPG-oligonucleotideIBA 10/2010
1	RNA (Ribonucleic Acid)IBA 03/2009
1	Surface Antigens (Surface Antigen)IBA 11/2007
1	AerosolsIBA 07/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2006
1	Bacterial VaccinesIBA 02/2004
1	Subunit VaccinesIBA 02/2004

Therapy/Procedure

2	Punctures 03/2015 - 02/2004
2	Ligation 03/2015 - 02/2004
2	Therapeutics 12/2003 - 03/2003
1	Oral Administration 10/2014
1	Intranasal Administration 10/2008